Here are three top-rated consumer dividend stocks that have yields above 3% and have made their way onto the coveted Zacks Rank #1 (Strong Buy) list.
Investors with an interest in Consumer Products - Staples stocks have likely encountered both Kenvue (KVUE) and L'Oreal SA (LRLCY). But which of these two stocks is more attractive to value investors?
Kimberly-Clark Corp (NYSE:KMB, XETRA:KMY) has earned a repeat ‘Buy' rating and $120 price objective from Bank of America analysts, who believe that the company's acquisition of Kenvue assets could create long-term value despite near-term integration challenges. The analysts said the deal appears opportunistic, noting the acquisition multiple of about 14 times Kenvue's last-twelve-month adjusted EBITDA and a purchase price of $21.01 per share, roughly in line with Kenvue's market value before Tylenol-related headlines weighed on the stock in September 2025.
| Household Products Industry | Consumer Staples Sector | Kirk L. Perry CEO | XETRA Exchange | US49177J1025 ISIN |
| US Country | 22,000 Employees | 13 May 2026 Last Dividend | - Last Split | 4 May 2023 IPO Date |
Kenvue Inc. is a global consumer health firm that offers a wide range of healthcare products through its diverse operational segments: Self Care, Skin Health and Beauty, and Essential Health. Founded in 2022 and headquartered in Skillman, New Jersey, Kenvue Inc. delivers a comprehensive portfolio of products designed to improve the wellness and health of consumers around the world. By leveraging well-known brands across its segments, Kenvue provides solutions for everyday health concerns, from pain relief and cold prevention to skincare and baby care.